Blencowe Resources: Aspiring to become one of the largest graphite producers in the world. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSpectra (unres) Regulatory News (SPSY)

Share Price Information for Spectra (unres) (SPSY)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 231.00
Bid: 224.00
Ask: 238.00
Change: 1.00 (0.43%)
Spread: 14.00 (6.25%)
Open: 230.00
High: 232.00
Low: 230.00
Prev. Close: 230.00
SPSY Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim results

30 Sep 2014 07:00

RNS Number : 9210S
Spectra Systems Corporation
30 September 2014
 



Spectra Systems Corporation

Interim results for the six months ended 30 June 2014

 

Spectra Systems Corporation, a leading provider of advanced technology solutions for banknote and product authentication, is pleased to announce its interim results for the six months ended 30 June 2014.

 

 

Financial highlights ($000's):

 

-Revenue 255% ahead of last year at $9,807 (2013: $2,761)

 

-Transition into profit with basic earnings before taxation of USD $769 (2013: ($1,292))

 

-Basic earnings per share of $0.01 (2013: ($0.03))

 

-Strong, debt-free balance sheet, with cash of $9,637 (2013: $14,231) at 30 June

 

 

Commenting on the results, Nabil Lawandy, Chief Executive Officer, said:

 

"The Company's revenues have increased by over 255% and losses last year have turned into positive earnings. This strong performance is fuelled by the combination of high demand for our consumables and the ongoing delivery of sensors to a G8 central bank, which underpins the use of our consumables for the next decade. Additionally, strong performances from the now fully integrated acquisitions in both physical and software based technologies continue and are expected to further support our expectation for a satisfactory year-end profit performance.

"In 2013 we introduced a new technology for cleaning soiled banknotes which has the potential to expand our business within the banknote industry through products which reduce cost and environmental disposal issues facing central banks. We have made steady progress working collaboratively with central banks to validate the technology and determine its suitability for various banknote designs and processing scenarios. Based on the continuing interest in the technology, we have selected a partner to develop a commercial product. In parallel, we have continued to file intellectual property to protect the technology and expect to have the first feedback on the earliest patents filed by close of 2014.

"Notwithstanding the strong performance in H1-2014, we have begun a cost cutting initiative which will be completed by year-end. This initiative will allow us to lower operating costs following the conclusion of the sensor manufacturing referred to above, while at the same time maintain our ability to respond to new opportunities.

"The Board believes that the various opportunities available to the Group will offset the sensor manufacturing revenues which are scheduled to conclude in H1-2015.

"The Board therefore believes that the Company, by achieving key business milestones, will continue to perform well for the remainder of 2014 and continues to have excellent prospects."

 

Enquiries:

 

Spectra Systems Corporation

Dr. Nabil Lawandy, Chief Executive Officer

Tel: +1 (0) 401 274 4700

WH Ireland Limited

Tel: +44 (0) 20 7220 1650

Chris Fielding (Head of Corporate Finance)

Chief Executive Officer's statement

 

The Company has achieved key commercial milestones in the first half:

· Increased revenues well above 2013 and achieved first half profitability.  

· The successful delivery of another large consumables order to a central bank customer and additional orders for this year. 

· The delivery of sensors to a G8 central bank has added strong support to the continued longevity of our consumable sales to customers once they adopt our technologies. Delivery of sensors will continue through H1- 2015 contributing to our 2015 financial performance. 

· Phosphour sales have returned to their high historical levels and have already exceeded the 2014 full year plan. 

· Completed the acquisition of Inksure and fully integrated the operation without additional staffing. Sales of consumables and hand-held readers, as well as licensing revenue from customers we acquired, have been on plan. 

· Contract renewals and upselling to our customers in the gaming software security industry. 

· The qualification of our manufacturing facility by a major worldwide supplier of banknote printing services and paper, as well as the initiation of the material qualification program by a G8 customer. 

· The continuing trials with central banks for our AerisTM banknote cleaning technology and our selection of a machine development partner, Cool Clean Technologies, to produce a commercial system.  

 

Financial overview ($000's)

 

Revenue in the first half of the current year amounted to $9,807 (2013: $2,761), which is 255% higher than the prior year. Basic profit for the first half amounted to $769 (2013: ($1,292)).

 

Operating expenses for the first half of 2014, $3,808, are higher compared with the first half of 2013, $3,008, due to royalties associated with increased material sales, legal fees related to the lawsuit settlement (note 3 to the financial statements), and additional costs related to developing and marketing our AerisTM technology.

 

Cash and investments at the period end amounted to $9,637 (2013: $14,231). The Company purchased the assets of Inksure Technologies, Inc. for approximately $1.5M (note 4 to the financial statements), settled the lawsuit for $2M, and transferred $1.5M to restricted cash to comply with the provisions of a major contract.

 

  

Strategy

The company's strategy for increasing revenue and earnings is based on:

· Integrating our new generation, fully developed, machine-readable covert authentication materials into public security features for banknote authentication.  

· Marketing our new smartphone based TruBrandTM technology for brand protection with a focus on Asia. 

· Expanding our Secure Software Transactions group contributions by;

a. Providing higher value product upgrades to existing customers

b. Expanding our presence in the growing internet-based gaming sector

c. Bundling our software transaction capabilities with our physical security solutions to provide track and trace capabilities to our customers 

· Continuing cooperative work with central banks to evaluate the technology for their specific designs and create a market for our AerisTM banknote cleaning technology. In addition, we have begun work on developing additional banknote related uses for AerisTM which will require on-going consumables. 

· Reducing operating costs through staff reductions on hardware manufacturing while maintaining the ability to respond to new sensor opportunities for our other covert technologies.

· Transitioning our manufacturing of materials to in-house production and increasing margins on our product sales to 18 central banks.  

The strategy described has components which have been ongoing and reflect the longer sales cycle of central banks as well as two new products which are disruptive technologies where we believe we have a controlling position. These are the smartphone authentication (TruBrandTM) and banknote cleaning technologies. With respect to the former, although several companies, including Inksure, had attempted to provide such authentication in the past, it has not been robust enough to gain traction.

TruBrandTM technology is highly robust and operates in all environments with ease and reliability for the user, which in this case, is the retail consumer. In addition, its value is enhanced to brand owners by the ability of the system to provide them with customer data, such as location and time, for improved marketing of their products.

AerisTM, our banknote cleaning technology, has the potential to save central banks significant amounts of money spent on replacing banknotes every year. Our decade long relationships with central banks, which appreciate the quality and performance of our covert authentication products, have allowed us to rapidly initiate tests with them to assist them in evaluating the business case for AerisTM within the context of their specific processing methods and equipment. We believe that this technology will be supported by intellectual property protection resulting in a competitor-free business opportunity which is potentially, substantially larger than the authentication business.  

Prospects

The Company's prospects have grown through the combination of products from the Inksure acquisition and integration, the completion of the TruBrandTM mobile phone technology, the marketing of our fully developed second generation authentication technology, and the validation of AerisTM by central banks.

Near term prospects for increased sales of our suite of brand authentication products are in Asia where we have had ongoing discussions with current customers to expand their use of our materials to more of their products. In addition, we have invested over a year of effort into the introduction of TruBrandTM with a major producer of spirits in Asia where we continue to gain traction.

Our new generation covert authentication products that have been developed and tested on a large scale, are under consideration by a number of central banks. These include both substrate and ink borne versions which are compatible with both paper and polymer notes.

Our cooperative testing with central banks, of our AerisTM technology, which removes soiling substances from banknotes without significantly damaging the costly security features or compromising print, has the potential of changing the economics of banknote production in many central banks. Based on the continued growth in banknote production to the level of nearly 150 billion banknotes per year at a cost approaching $10 billion annually, along with ongoing test programs which will provide us important feedback to allow us to improve the process and refine our understanding of the business potential for the product, we expect that we will be able to install a system within the next two years.

The Board believes that these opportunities will offset the sensor manufacturing revenues which are scheduled to be concluded in H1-2015.

The Board therefore believes that the Company remains on track to deliver a satisfactory year-end profit performance and continues to have excellent prospects.

 

Nabil M. Lawandy

Chief Executive Officer

September 30, 2014

 

 

 

 

Statements of income and other comprehensive income

for the half year ended 30 June 2014

 

Restated

Half Year

Half Year

Year to

to 30/6/14

to 30/6/13

31/12/13

Unaudited

Unaudited

Audited

Note

USD'000

USD'000

USD'000

Revenue

9,807

2,761

11,572

Cost of sales

(5,266)

(1,125)

(6,007)

--------

------------------

------------------

------------------

Gross profit

4,541

1,636

5,565

Operating expenses

(3,808)

(3,008)

(6,917)

--------

------------------

------------------

------------------

Operating profit / (loss)

733

(1,372)

(1,352)

Investment income

36

80

139

Contingent liability

-

-

(1,789)

Profit / (loss) before taxation

--------

------------------

769

------------------

(1,292)

------------------

(3,002)

--------------------------------------

--------

------------------

------------------

------------------

Taxation

(308)

-

-

Profit / (loss) for the period

461

(1,292)

(3,002)

--------------------------------------

--------

------------------

------------------

------------------

Loss per share:

Basic earnings / (loss) per share

Diluted earnings / (loss) per share

2

0.01

0.01

(0.03)

-

(0.07)

-

--------------------------------------

--------

------------------

------------------

------------------

Other comprehensive income (loss):

Unrealized gain on currency exchange

20

11

11

Reclassification for realized amounts

included in basic profit (loss)

-

(13)

(13)

--------

------------------

------------------

------------------

Total other comprehensive income (loss)

20

(2)

(2)

Comprehensive income (loss)

481

(1,294)

(3,004)

All of the Group's operations are continuing.

Balance sheets

as at 30 June 2014

 

Restated

As at

As at

As at

30/6/14

30/6/13

31/12/13

Unaudited

Unaudited

Audited

USD'000

USD'000

USD'000

Current assets

Inventories

3,338

2,216

2,969

Trade and other receivables

2,397

1,226

2,289

Cash and cash equivalents

9,637

10,931

13,435

Investments

-

3,300

-

Unbilled revenue

-

324

-

Deferred contract costs

-

327

10

Deferred tax asset

36

344

344

Prepaid expenses

221

69

157

--------------------------------------

--------

------------------

------------------

------------------

Total current assets

15,629

18,737

19,204

--------------------------------------

--------

------------------

------------------

------------------

Non-current assets

Intangible assets

4,149

3,170

3,075

Property, plant and equipment

3,027

2,613

2,903

Restricted cash

2,500

1,050

2,500

Other assets

23

32

74

Deferred tax asset

902

902

902

--------------------------------------

--------

------------------

------------------

------------------

Total non-current assets

10,601

7,767

9,454

--------------------------------------

--------

------------------

------------------

------------------

Total assets

26,230

26,504

28,658

--------------------------------------

--------

------------------

------------------

------------------

Current liabilities

Trade and other payables

1,337

711

1,633

Accrued expenses and other

777

757

927

Deferred revenue

2,295

1,974

3,040

--------------------------------------

--------

------------------

------------------

------------------

Total current liabilities

4,409

3,442

5,600

--------------------------------------

--------

------------------

------------------

------------------

Non-current liabilities

Deferred revenue

348

179

103

Contingent liability

3

-

271

2,000

--------------------------------------

--------

------------------

------------------

------------------

Total non-current liabilities

348

450

2,103

--------------------------------------

--------

------------------

------------------

------------------

Total liabilities

4,757

3,892

7,703

--------------------------------------

--------

------------------

------------------

------------------

Shareholders' equity

Common stock

453

453

453

Additional paid in capital

54,893

54,803

54,856

Accumulated other comprehensive (loss)

15

(5)

(5)

Accumulated deficit

--------

(33,888)

------------------

(32,639)

------------------

(34,349)

------------------

Shareholders' equity

21,473

22,612

20,955

--------------------------------------

--------

------------------

------------------

------------------

Total liabilities & shareholders' equity

26,230

26,504

28,658

--------------------------------------

--------

------------------

------------------

------------------

 

 

 

Statements of cash flows

for the half year ended 30 June 2014

 

Restated

Half Year

Half Year

Year to

to 30/6/14

to 30/6/13

31/12/13

Unaudited

Unaudited

Audited

USD'000

USD'000

USD'000

Profit / (loss) before taxation

461

(1,292)

(3,002)

Depreciation and amortisation

350

154

429

Stock compensation expense

40

64

116

Income tax expense

308

Allowance for Solaris note

-

-

94

Trade and other receivables

(110)

1,723

529

Unbilled revenue on contracts in progress

-

30

355

Deferred contract costs

10

17

334

Inventories

(370)

(1,076)

(1,894)

Other assets

-

-

22

Prepaid expenses

(60)

112

(29)

Trade and other payables

(300)

(1,007)

250

Accrued expenses and other

(137)

(100)

(5)

Deferred revenue

(500)

(224)

783

Contingent liability

(2,000)

-

1,729

Net used in operating activities

-------

------------------

(2,308)

------------------

(1,599)

------------------

(289)

--------------------------------------

--------

------------------

------------------

------------------

Investing activities

Increase in restricted cash / investments

-

-

(1,450)

Purchases of property, plant

and equipment

(220)

(366)

(772)

Other long-term assets

(60)

63

-

Asset acquisitions

(1,080)

-

-

Payments of patent costs

(140)

(66)

(226)

Sales of investments

-

3,250

6,560

Net cash provided by / (used in) investing

--------

------------------

------------------

------------------

activities

(1,500)

2,881

4,112

--------------------------------------

--------

------------------

------------------

------------------

Effect of exchange rate changes on cash

and cash equivalents

10

31

(5)

Net(decrease)/increase in cash

and cash equivalents

(3,798)

1,313

3,818

Cash and cash equivalents at

start of period

13,435

9,617

9,617

Cash and cash equivalents at

--------

------------------

------------------

------------------

end of period

9,637

10,931

13,435

--------------------------------------

--------

------------------

------------------

------------------

 

 

 

 

Notes to financial information

 

1. Basis of preparation

 

This report was approved by the Directors on 29 September 2014.

 

The interim results for the half year ended 30 June 2014 have been prepared in accordance with the AIM Rules for Companies. The Group has not elected to apply IAS 34 Interim financial reporting.

This financial information has been prepared using the recognition and measurement principles of US Generally Accepted Accounting Principles.

 

The principal accounting policies used in preparing the interim results are those the Company expects to apply in its financial statements for the year ending 31 December 2014 and are unchanged from those disclosed in the Company's Annual Report for the year ended 31 December 2013.

 

The results for the half year are unaudited. The financial information for the year ended 31 December 2013 does not constitute the full statutory accounts for that period. The Annual Report and financial statements for the year ended 31 December 2013 have been filed with the Registrar of Companies. The Independent Auditors' Report on the financial statements for the year ended 31 December 2013 was unqualified and did not draw attention to any matters by way of emphasis.

 

2. Earnings per share

 

The calculation of earnings per share figures for the half year ended 30 June 2014 is based on the profit / (loss) attributable to ordinary shareholders of USD 461,000 (2013 half year: USD(1,292,000); 2013 full year: USD(3,002,000) divided by the basic and weighted average number of shares in issue, shown in the table below.

 

Half year

to 30/6/14

Half year

to 30/6/13

Year

to 31/12/13

Number of shares

Weighted average

Number of shares

Weighted average

Number of shares

Weighted average

Basic-

shares in issue

45,251,370

45,251,370

45,251,370

45,251,370

45,251,370

45,251,370

Share options

6,520,103

6,525,202

-

-

-

-

Weighted average no. of shares

51,776,572

45,251,370

45,251,370

 

The calculation of diluted earnings per share assumes conversion of all potentially dilutive ordinary shares, all of which arise from share options. A calculation is done to determine the number of shares that could have been acquired at fair value, based upon the monetary value of the subscription rights attached to outstanding share options. Share options are anti-dilutive and are therefore only included at 30 June 2014.

 

3. Lawsuit settlement

 

In December 2011, the Company was notified by a corporate shareholder regarding a license agreement between the Company and the shareholder dated March 8, 1999. The shareholder had stated that the Company owes the shareholder approximately $2,100,000 in total for the years 2004 through 2010 based on their interpretation of the license agreement.

 

In H1-2014, the Company and the shareholder entered into an agreement to settle the dispute for all past amounts due and all future amounts that may be due, the Company agreed to pay $2,000,000 plus the relief of a receivable owed the Company from the shareholder in the amount of approximately $129,000. Accordingly, the Company recorded a contingent liability expense of $1,789,040 in 2013. 

 

4. Acquisition of certain assets from Inksure Technologies, Inc.

 

On February 28, 2014, the Company acquired, certain assets from Inksure Technologies, Inc., a leader in brand protection and tax stamp authentication headquartered in New York City, NY. The acquisition was strategic for the Company allowing us to extend our reach into tax stamps and the authentication of commercial product brands. The Company will support the customers with resources existing in its banknote authentication division. The total purchase price was $1,356,000 in cash with deferred consideration of $35,000, dependent upon achieving a commercial milestone. The purchase price included Inksure's long-standing customer relationships and authentication technology.

 

5. Prior year restatement

During the year-end financial close process for 2013, the Company discovered an error related to accounting for foreign currency exchange transactions during 2012 and 2011. The Company had accounted for realized gain and losses on such transactions as a charge to Other Comprehensive Income (Loss) which is a component of Total Stockholders Equity. These realized gains and losses should have been included as part of Net Income (Loss) on the Statement of Income. The result of this error had no effect on Total Stockholder's Equity. The Company is restating its financial statements as of and for the period ended 30 June 2013

6. Copies of this statement are available to the public from the Registered Office at: 321 South Main Street, Suite 102, Providence, RI 02903 USA.

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR LLMFTMBJTBTI
Date   Source Headline
3rd Apr 20247:00 amRNSCertified Circular Polymer Banknote Substrate
27th Mar 20247:00 amRNSAudited results for 12 months ended 31 Dec 2023
13th Mar 20243:07 pmRNSNotice of Results
11th Jan 20247:00 amRNSExercise of Options and Director/PDMR Shareholding
28th Dec 20237:00 amRNSExercise of Options
21st Dec 202312:15 pmRNSCompletion of Acquisition
15th Dec 20234:35 pmRNSExercise of Options and transfer of shares
4th Dec 20237:00 amRNSAcquisition of Cartor Holdings Limited
6th Nov 20234:43 pmRNSTR-1
12th Oct 20237:00 amRNSLargest Central Bank Consumables Order
25th Sep 20237:00 amRNSInterim Results for Six Months Ended 30 June 2023
6th Sep 20237:00 amRNSResults for the 6 months ended 30 June 2023
7th Jul 20236:01 pmRNSRemoval of Regulation S restrictions from shares
26th Jun 20233:22 pmRNSAnnual General Meeting Lack of Quorum
14th Jun 20237:00 amRNSUpdate on Development Contracts
30th May 20237:00 amRNSAppointment of Chief Financial Officer
25th Apr 20237:00 amRNSAdditional Sensor Services Contract Amendment
24th Apr 20237:00 amRNSResignation of Chief Financial Officer
19th Apr 20237:05 amRNSRemoval of Reg S restrictions from common stock
6th Apr 20237:00 amRNSExercise of Options
31st Mar 20235:14 pmRNSRemoval of Reg S restrictions from shares
21st Mar 202311:44 amRNSDividend Record Date
20th Mar 20237:00 amRNSAudited results for year ended 31 December 2022
16th Mar 20234:35 pmRNSExercise of Options
13th Mar 20237:00 amRNSNotice of Results
6th Mar 202310:39 amRNSRemoval of Reg S restrictions from common stock
11th Oct 20226:12 pmRNSDirector/PDMR Shareholding
3rd Oct 20227:00 amRNSContract Amendment to a Central Bank
21st Sep 20227:00 amRNSExercise of Options
12th Sep 20227:05 amRNSAppointment of Non-Executive Director
12th Sep 20227:00 amRNSInterim Results for Six Months Ended 30 June 2022
16th Aug 20227:00 amRNSFirst Banknote Disinfection System Sold
15th Aug 20227:00 amRNSNew Central Bank Contract Amendment
28th Jul 20227:00 amRNSShare Buy-Back
1st Jul 20222:31 pmRNSShare Buy-Back
28th Jun 20227:00 amRNSShare Buy-Back
15th Jun 20227:00 amRNSAdditional Central Bank Development Revenues
14th Jun 20227:00 amRNSAppointment of Chief Financial Officer
13th Jun 20227:00 amRNSUpdate regarding Solaris
13th Jun 20227:00 amRNSAnnual General Meeting Update
25th May 20227:00 amRNSExercise of Options and Director/PDMR Shareholding
20th May 20228:44 amRNSRemoval of Regulation S restrictions from shares
20th May 20228:41 amRNSResignation of Chief Financial Officer
3rd May 20227:00 amRNSPosting of Annual Report & Notice of AGM
6th Apr 20221:36 pmRNSRemoval of Reg S restrictions from common stock
28th Mar 20227:00 amRNSGrant of Share Options
21st Mar 20227:00 amRNSResults twelve months ended 31 December 2021
24th Feb 20227:00 amRNSSpectra Introduces Covert Polymer Substrate
24th Jan 20227:00 amRNSNew contract awards
21st Jan 20227:00 amRNSExercise of Options

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.